Back

Asahi Intecc Co., Ltd.

Data quality: 100%

Overbought

AHICF

OTC Healthcare Medical - Instruments & Supplies

$20.37

$0.00 (0.00%)

Mkt Cap: 5.40B

Day Range

$17.95 $20.37

52-Week Range

$15.08 $21.08

Volume

50D / 200D Avg

$19.28 / $17.74

Prev Close

$20.37

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric	Stock	Sector Median
P/E	0.4	0.4
P/B	0.0	2.9
ROE %	8.4	3.8
Net Margin %	10.6	3.9
Rev Growth 5Y %	18.2	10.0
D/E	0.1	0.2

Key Takeaways

Revenue grew 18.19% annually over 5 years — strong growth

Earnings declined -19.43% over the past year

Debt/Equity of 0.07 — conservative balance sheet

Generating 31.97B in free cash flow

P/E of 0.42 — trading at a low valuation

Revenue growth is decelerating — 1Y growth trails 5Y average by 6.59%

Growth

Revenue Growth (5Y)

18.19%

Revenue (1Y)11.60%

Earnings (1Y)-19.43%

FCF Growth (3Y)123.05%

Quality

Return on Equity

8.44%

ROIC13.96%

Net Margin10.61%

Op. Margin25.06%

Safety

Debt / Equity

0.07

Current Ratio3.71

Interest Coverage140.56

Valuation

P/E Ratio

0.42

P/B Ratio0.04

EV/EBITDA-1.25

Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y)	11.60%	Revenue Growth (3Y)	15.42%
Earnings Growth (1Y)	-19.43%	Earnings Growth (3Y)	-1.42%
Revenue Growth (5Y)	18.19%	Earnings Growth (5Y)	6.28%
Profitability
Revenue (TTM)	120.03B	Net Income (TTM)	12.74B
ROE	8.44%	ROA	6.59%
Gross Margin	67.68%	Operating Margin	25.06%
Net Margin	10.61%	Free Cash Flow (TTM)	31.97B
ROIC	13.96%	FCF Growth (3Y)	123.05%
Safety
Debt / Equity	0.07	Current Ratio	3.71
Interest Coverage	140.56	Dividend Yield	0.01%
Valuation
P/E Ratio	0.42	P/B Ratio	0.04
P/S Ratio	0.05	PEG Ratio	-2.56
EV/EBITDA	-1.25	Dividend Yield	0.01%
Market Cap	5.40B	Enterprise Value	-37.70B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	120.03B	107.55B	90.10B	77.75B	61.51B
Net Income	12.74B	15.81B	13.11B	10.86B	9.98B
EPS (Diluted)	46.92	58.20	48.25	40.00	38.07
Gross Profit	81.24B	69.05B	58.83B	51.08B	41.47B
Operating Income	30.08B	22.14B	18.03B	15.24B	12.80B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	193.19B	191.61B	172.64B	155.13B	115.43B
Total Liabilities	41.84B	39.66B	38.35B	34.00B	22.49B
Shareholders' Equity	150.56B	151.21B	132.31B	119.46B	92.91B
Total Debt	11.10B	6.70B	14.25B	12.18B	8.04B
Cash & Equivalents	54.20B	35.66B	34.88B	32.32B	21.36B
Current Assets	103.36B	94.70B	90.26B	79.61B	61.13B
Current Liabilities	27.86B	29.49B	26.32B	20.76B	14.67B

Strategy Scores

This stock passed the criteria for 4 strategies

Score = fit strength (0–100)

Rank = position among all matches

Custom Cash Flow Compounder

#158 of 1024

Custom Deep Value Investing (Seth Klarman)

#366 of 820

Growth Price/Sales Ratio Focus (Ken Fisher)

#449 of 616

Value Defensive Investing (Benjamin Graham)

#527 of 708

Recent Activity

Entered Cash Flow Compounder

Mar 24, 2026

Entered Deep Value Investing (Seth Klarman)

Mar 24, 2026

Entered Price/Sales Ratio Focus (Ken Fisher)

Mar 24, 2026

Entered Defensive Investing (Benjamin Graham)

Mar 24, 2026